An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia
详细信息 查看全文
- 作者：Natasa Gisev ; Suzanne Nielsen ; Elena Cama…
- 关键词：Analgesics ; Opioids ; Non ; prescription drugs ; Codeine ; Pharmacoepidemiology ; Drug utilisation
- 刊名：European Journal of Clinical Pharmacology
- 出版年：2016
- 出版时间：April 2016
- 年：2016
- 卷：72
- 期：4
- 页码：469-494
- 全文大小：757 KB
- 参考文献：1.International Narcotics Control Board 2015 Narcotic drugs estimated world requirements for 2015—statistics for 2013. https://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2014/ND_TR_2014_2_Comments_EN.pdf . Accessed 23 October 2015.
2.Hollingworth SA, Gray PD, Hall WD, Najman JM (2015) Opioid analgesic prescribing in Australia: a focus on gender and age. Pharmacoepidemiol Drug Saf 24:628–636CrossRef PubMed
3.Degenhardt L, Gisev N, Cama E, Nielsen S, Larance B, Bruno R (2015) The extent and correlates of community-based pharmaceutical opioid utilisation in Australia. Pharmacoepidemiol Drug Saf (in press)
4.Therapeutic Guidelines Writing Group (2012) Therapeutic Guidelines: analgesic version 6. Therapeutic Guidelines Limited, North Melbourne
5.Tobin CL, Dobbin M, McAvoy B (2013) Regulatory responses to over-the-counter codeine analgesic misuse in Australia, New Zealand and the United Kingdom. Aust N Z J Public Health 37:483–488CrossRef PubMed
6.Myers B, Siegfried N, Parry CD (2003) Over-the-counter and prescription medicine misuse in Cape Town—findings from specialist treatment centres. S Afr Med J 93:367–370PubMed
7.Dutch MJ (2008) Nurofen Plus misuse: an emerging cause of perforated gastric ulcer. Med J Aust 188:56–57PubMed
8.Roxburgh A, Hall W, Burns L, Pilgrim J, Saar E, Nielsen S, Degenhardt L (2015) Trends and characteristics of accidental and intentional codeine overdose deaths in Australia. Med J Aust 203:209 210.5694/mja5615.00183CrossRef
9.McAvoy BR, Tobin CL (2014) Fatal misuse of codeine-ibuprofen analgesics in Victoria, Australia. Med J Aust 200:150–151CrossRef PubMed
10.Frei M, Nielsen S, Tobin C, Dobbin M (2010) Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases. Med J Aust 193:294–296PubMed
11.Dyer BT, Martin JL, Mitchell JL, Sauven NC, Gazzard B (2004) Hypokalaemia in ibuprofen and codeine phosphate abuse. Int J Clin Pract 58:1061–1062CrossRef PubMed
12.Medani S, Short S, Wall C (2010) Nurofen plus toxicity—what should nephrologists be alert to? Rare Complications of an Increasingly Misused Medication NDT Plus doi: 10.1093/ndtplus/sfq079.
13.Robinson GM, Robinson S, McCarthy P, Camero C (2010) Misuse of over-the-counter codeine-containing analgesics: dependence and other adverse effects. N Z Med J 123:59–64PubMed
14.McAvoy BR, Dobbin MD, Tobin CL (2011) Over-the-counter codeine analgesic misuse and harm: characteristics of cases in Australia and New Zealand. N Z Med J 124:29–33PubMed
15.Evans C, Chalmers-Watson TA, Gearry RB (2010) Combination NSAID-codeine preparations and gastrointestinal toxicity. N Z Med J 123:92–93PubMed
16.Nielsen S, Murnion B, Dunlop A, Degenhardt L, Demirkol A, Muhleisen P, Lintzeris N (2015) Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series. Drug Alcohol Rev 34:304–311CrossRef PubMed
17.Nielsen S, Roxburgh A, Bruno R, Lintzeris N, Jefferson A, Degenhardt L (2015) Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011. Drug Alcohol Depend 149:212–219CrossRef PubMed
18.Stosic R, Dunagan F, Palmer H, Fowler T, Adams I (2011) Responsible self-medication: perceived risks and benefits of over-the-counter analgesic use. Int J Pharm Pract 19:236–245CrossRef PubMed
19.Therapeutic Goods Administration 2015 Consultation: invitation for public comment - ACMS meeting, July 2015. https://www.tga.gov.au/consultation-invitation/consultation-invitation-public-comment-acms-meeting-july-2015 . Accessed 26 October 2015.
20.Blanch B, Pearson SA, Haber PS (2014) An overview of the patterns of prescription opioid use, costs and related harms in Australia. Br J Clin Pharmacol 78:1159–1166CrossRef PubMed PubMedCentral
21.World Health Organization (2003) Introduction to drug utilization research. World Health Organization, Geneva
22.Arora S, Roxburgh A, Bruno R, Nielsen S, Burns L (2013) A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs. Drug Alcohol Rev 32:574–581CrossRef PubMed
23.Nielsen S, Cameron J, Lee N (2011) Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: implications for intervention and prevention. J Opioid Manag 7:363–370PubMed
24.IBISWorld 2015 IBISWorld Industry Report G4271a Pharmacies in Australia http://clients1.ibisworld.com.au/reports/au/industry/keystatistics.aspx?entid=1878 . Accessed 26 October 2015.
25.World Health Organization Collaborating Centre for Drugs Statistics Methodology 2013 ATC/DDD Index 2015. Norweigan Institute of Public Health http://www.whocc.no/atc_ddd_index/ . Accessed 16 June 2015.
26.Australian Bureau of Statistics 2013 1270.0.55.006—Postcode 2011 to Statistical Local Area 2011. http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/1270.0.55.006July%202011?OpenDocument . Accessed 31 August 2014.
27.Australian Bureau of Statistics 2007 1216.0.15.003—Australian Standard Geographical Classification (ASGC) Remoteness Area Correspondences, 2006. http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/1216.0.15.003Main+Features12006?OpenDocument . Accessed 31 August 2014.
28.Australian Bureau of Statistics 2011 1216.0—Australian Standard Geographical Classification (ASGC), July 2011. http://www.abs.gov.au/ausstats/abs@.nsf/mf/1216.0 . Accessed 31 August 2014.
29.Australian Bureau of Statistics 2014 3235.0—Population by age and sex, regions of Australia, 2013. http://www.abs.gov.au/Ausstats/abs@.nsf/mf/3235.0 . Accessed 31 August 2014.
30.Australian Bureau of Statistics 2014 Table Builder Pro http://www.abs.gov.au/websitedbs/censushome.nsf/home/tablebuilder?opendocument&navpos=240 . Accessed 31 August 2014.
31.Maven Marketing 2014 List of Pharmacies and Chemists in Australia http://www.mavenmarketing.com.au/list-of-pharmacies-in-australia/ . Accessed 14 March 2015.
32.Environmental Systems Research Institute Inc. (2013) ESRI ArcGIS Desktop 10.2. ESRI, California.
33.Henricson K, Carlsten A, Ranstam J, Rametsteiner G, Stenberg P, Wessling A, Melander A (1999) Utilisation of codeine and propoxyphene: geographic and demographic variations in prescribing, prescriber and recipient categories. Eur J Clin Pharmacol 55:605–611CrossRef PubMed
34.Prunuske JP, St Hill CA, Hager KD, Lemieux AM, Swanoski MT, Anderson GW, Lutfiyya MN (2014) Opioid prescribing patterns for non-malignant chronic pain for rural versus non-rural US adults: a population-based study using 2010 NAMCS data. BMC Health Serv Res 14:563 510.1186/s12913-12014-10563-12918CrossRef PubMed PubMedCentral
35.Gudin J, Lee AJ (2013) The downside of upscheduling. Pain Med 14:1628–1629CrossRef PubMed
36.Kolodny A (2013) Better late than never: time to up-schedule hydrocodone combination products. Pain Med 14:1627–1628CrossRef PubMed
37.Pilgrim JL, Dobbin M, Drummer OH (2013) Fatal misuse of codeine-ibuprofen analgesics in Victoria, Australia. Med J Aust 199:329–331CrossRef PubMed
38.Samuelsen P-J, Slørdal L, Mathisen UD, Eggen AE (2015) Analgesic use in a Norwegian general population: change over time and high-risk use—the Tromsø Study. BMC Pharmacol Toxicol 16:16. doi:10.1186/s40360-40015-40016-y CrossRef PubMed PubMedCentral
39.Butcher BE, Carmody JJ (2012) Sex differences in analgesic response to ibuprofen are influenced by expectancy: a randomized, crossover, balanced placebo-designed study. Eur J Pain 16:1005–1013CrossRef PubMed
40.Campbell G, Nielsen S, Bruno R, Lintzeris N, Cohen M, Hall W, Larance B, Mattick RP, Degenhardt L (2015) The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain 156:231–242CrossRef PubMed
41.Bicket MC, Mao J (2015) Chronic pain in older adults. Anesthesiol Clin 33:577–590CrossRef PubMed
42.Davies EA, O’Mahony MS (2015) Adverse drug reactions in special populations—the elderly. Br J Clin Pharmacol: Published online 22 May 2015. doi: 2010.1111/bcp.12596
43.Australian Medicines Handbook (2015). Australian Medicines Handbook Pty Ltd, Adelaide.
44.García Rodríguez L, Cattaruzzi C, Troncon M, Agostinis L (1998) Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 158:33–39
45.Singh G (2000) Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, rheumatism, and aging medical information system. Am J Ther 7:115–121CrossRef PubMed
46.Tarone RE, Blot WJ, McLaughlin JK (2004) Nonselective nonaspirin nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding: relative and absolute risk estimates from recent epidemiologic studies. Am J Ther 11:17–25CrossRef PubMed
47.Ferrari A, Baraldi C, Sternieri E (2015) Medication overuse and chronic migraine: a critical review according to clinical pharmacology. Expert Opin Drug Metab Toxicol 11:1127–1144CrossRef PubMed
48.Westergaard M, Hansen E, Glümer C, Jensen R (2015) Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse. Eur J Clin Pharmacol 71:851–860CrossRef PubMed
49.Zebenholzer K, Andree C, Lechner A, Broessner G, Lampl C, Luthringshausen G, Wuschitz A, Obmann S-M, Berek K, Wöber C (2015) Prevalence, management and burden of episodic and chronic headaches—a cross-sectional multicentre study in eight Austrian headache centres. J Headache Pain 16:46. doi:10.1186/s10194-10015-10531-10197 CrossRef PubMedCentral - 作者单位：Natasa Gisev (1)
Suzanne Nielsen (1)
Elena Cama (1)
Briony Larance (1)
Raimondo Bruno (1) (2)
Louisa Degenhardt (1)
1. National Drug and Alcohol Research Centre, UNSW, Australia, Sydney, NSW, 2052, Australia
2. School of Medicine, University of Tasmania, Hobart, Australia - 刊物类别：Biomedical and Life Sciences
- 刊物主题：Biomedicine
Pharmacology and Toxicology - 出版者：Springer Berlin / Heidelberg
- ISSN：1432-1041
文摘
Purpose The extent and factors associated with codeine use in the community remain poorly understood despite the widespread global use of codeine. The aim of this study was to examine the use of prescription and over-the-counter (OTC) codeine in Australia and identify the geographic and socio-demographic characteristics associated with prescription and OTC codeine use.